Tg Therapeutics (TGTX) Acquisitions (2011)
Tg Therapeutics' (TGTX) quarterly Acquisitions came in at $10386.0 in Q4 2011.
Tg Therapeutics (TGTX) Acquisitions (2011) Analysis & Trends
Tg Therapeutics' Acquisitions history runs 1 years deep, the most recent figure standing at $10386.0 for Q4 2011.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $10386.0 in Q4 2011; TTM through Sep 2012 was $10386.0, a N/A change from a year earlier, with the FY2012 full-year figure at $10386.0, changed N/A from the prior year.
- Acquisitions was little changed at $10386.0 in Q4 2011 per TGTX's latest filing.
- Across five years, Acquisitions topped out at $10386.0 in Q4 2011 and bottomed at $10386.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 10,386.00 |